期刊文献+

组织工程表皮与单核白血病细胞共培养的致敏性检测模型 被引量:1

A co-culture model of tissue engineering epidermis and THP-1 cells for sensitization testing
下载PDF
导出
摘要 背景:大量研究表明体外构建的组织工程皮肤可用于化学物质的刺激性检测。目的:构建组织工程表皮和单核白血病细胞共培养体外模型,并用致敏物初步验证。方法:利用人源性角质形成细胞构建组织工程表皮,和单核白血病细胞进行共培养,干预24h后,ELISA法检测空白对照组,溶剂对照组,二硝基氟苯处理组和十二烷基硫酸钠处理组培养液中白细胞介素1β的质量浓度,流式细胞术检测各组中单核白血病细胞表面标记物CD86和CD54的平均荧光强度。结果与结论:角质形成细胞气液界面培养14d后,苏木精-伊红染色结果显示构建的组织工程表皮含有8~10层细胞结构,泛角蛋白免疫组化染色阳性。二硝基氟苯处理组培养液中白细胞介素1β质量浓度,单核白血病细胞表面标记物CD86和CD54的平均荧光强度均高于溶剂对照组(P<0.05)。实验成功构建了组织工程表皮和单核白血病细胞共培养的致敏物检测模型。 BACKGROUND:Several studies have shown that tissue engineering skin are used for skin irritation testing.OBJECTIVE:To construct a co-culture model of tissue engineering epidermis and THP-1 cells,and to identify the specificity of the co-culture model to sensitizers.METHODS:Tissue engineering epidermis was constructed by human keratinocytes.Then,THP-1 cells were co-cultured tissue engineering epidermis.After 24 hours treatment on tissue engineering epidermis,the cultured medium and THP-1 cells were collected,respectively.ELISA was used to detect the concentration of interleukin 1beta (IL-1β) in the culture medium,and the mean fluorescence intensities (MFI) measured by flow cytometry were used to evaluate the expression of CD86 and CD54 on THP-1 cells.RESULTS AND CONCLUSION:After 14 days keratinocytes were cultured at air-liquid interface,HE staining showed 8-10 layers in tissue engineering epidermis.And pan-keratin immuohistochemistry staining was positive.After 24 hours treatment of chemicals,the concentration of IL-1β and MFIs of CD86 and CD54 in DNFB-treated group were higher that that in vehicle control group (P〈0.05).The results prove that a co-culture model of tissue engineering epidermis and THP-1 cells was successfully established,and it can be used for sensitization test,which gives a new method for toxicity testing in vitro.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第20期3641-3644,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 江苏省自然科学基金项目(BK2008092)资助~~
  • 相关文献

参考文献19

  • 1Basketter DA,Selbie E,Scholes EW,et al.Results with OECD recommended positive control sensitizers in the maximization,Buehler and local lymph node assays.Food Chem Toxicol.1993; 31(1):63-67.
  • 2Haseman JK,Strickland J,Allen D,et al.Safety assessment of allergic contact dermatitis hazards:an analysis supporting reduced animal use for the murine local lymph node assay.Regul Toxicol Pharmacol.2010;59(1):191-196.
  • 3Tuschl H,Kovac R.Langerhans cells and immature dendritic cells as model systems for screening of skin sensitizers.Toxicol In Vitro.2001;15(4-5):327-331.
  • 4Ryan CA,Kimber I,Basketter DA,et al.Dendritic cells and skin sensitization:biological roles and uses in hazard identification.Toxicol Appl Pharmacol.2007;221(3):384-394.
  • 5Tuschl H,Kovac R,Weber E.The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals.Toxicol In Vitro.2000;14(6):541-549.
  • 6Hulette BA,Ryan CA,Gerberick GF.Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment.Toxicol Appl Pharmacol.2002;182(3):226-233.
  • 7Ashikaga T,Sakaguchi H,Sono S,et al.A comparative evaluation of in vitro skin sensitisation tests:the human cell-line activation test (h-CLAT) versus the local lymph node assay (LLNA).Altern Lab Anim.2010;38(4):275-284.
  • 8Sakaguchi H,Ashikaga T,Miyazawa M,et al.The relationship between CD86/CD54 expression and THP-1 cell viability in an in vitro skin sensitization test--human cell line activation test (h-CLAT).Cell Biol Toxicol.2009;25(2):109-126.
  • 9Van Och FM,Van Loveren H,Van Wolfswinkel JC,et al.Assessment of potency of allergenic activity of low molecular weight compounds based on IL-1alpha and IL-18 production by a murine and human keratinocyte cell line.Toxicology.2005; 210 (2-3):95-109.
  • 10State Council of the People's Republic of China.Administrative Regulations on Medical Institution.1994-09-01.

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部